The Meeting
On June 9-10th we joined with other astronauts on our mission to get adolescent vaccination back on track.
Check out the full meeting recordings here and the individual presentations in the agenda below:
On our two-day journey, we
- Explored the impacts of the COVID-19 pandemic on HPV vaccination and implications for progress towards Healthy People 2030
- Charted a path towards health equity in HPV vaccination among diverse communities and understand the impact of other key determinants on adolescent vaccination rates
- Learned valuable lessons from experts in overcoming real challenges to increase adolescent vaccination
SPEAKER BIOS
Agenda
DAY 1: June 9, 2021, 1:00 – 3:20 p.m. EST
1:00 p.m. LIFTOFF: Meeting Open
- Dr. Kristin Oliver, Co-Chair, National HPV Vaccination Roundtable/American Academy of Pediatrics (AAP)
- Dr. Rebecca Perkins, Co-Chair, National HPV Vaccination Roundtable/ American College of Obstetricians and Gynecologists (ACOG)
1:10 p.m. HPV Impact Story
1:15 p.m. OPENING REMARKS: Transmitting the Importance of Adolescent Population Health
1: 25 p.m. FEATURED PRESENTATION: Reaching New Heights Together: A National Perspective from the Director of CDC’s Immunization Services & the Chief Medical Officer of Texas Children’s Pediatrics
- Dr. Melinda Wharton, Director, Immunization Services Division, CDC
- Dr. Stanley Spinner, CMO, Texas Children's Pediatrics
Childhood immunization is down over 11 million doses due to pandemic health care disruptions. Protecting children from vaccine-preventable diseases has never been more important. Adolescent vaccine rates lag behind younger children, so we need to activate both the public and private sector to catch up for a safe return to in-person schooling this fall. This session will provide an overview of childhood visits and immunization in the U.S. and describe the efforts of a pediatric health care system to prioritize HPV vaccination as cancer prevention before, during and after the pandemic.
2:00 p.m. BREAK/MOONWALK AT HOME OR OFFICE
2:15 p.m. PANEL PRESENTATION: There’s Space for Everybody: A Panel on HPV Vaccination in Diverse Communities
NASA’s twitter motto is “there’s space for everybody.” We believe this applies to vaccination as well. Every child should be fully protected from vaccine-preventable diseases.
HPV vaccination rates for teens have traditionally been higher among communities of color than white populations thanks to strong public vaccination programs for children. Due to pandemic disruptions, overall adolescent immunization rates have fallen 15-20%, with HPV vaccination down 19.2% as of late April 2021. Rates have fallen more among public vaccine recipients, which tend to serve more diverse populations. Prior to the pandemic, males, rural teens and insured teens had lower vaccination rates.
This panel will present both recent research and insights from diverse organizations represented on the HPV Roundtable. This work represents efforts in Asian American, African American/Afro Caribbean, American Indian/Alaskan Native, and Latinx communities.
Moderator:
Speakers:
- Dr. William Calo, Penn State College of Medicine
- Dr. Milkie Vu, Emory University
- Dr. Isabel Scarinci, University of Alabama at Birmingham
- Dr. Patricia Jeudin, University of Miami; African-Caribbean Cancer Consortium
- Dr. Allison Empey, Oregon Health & Science University; Chair, Committee on Native American Child Health, American Academy of Pediatrics
Suggested Pre-Reading:
- Disparities and Reverse Disparities in HPV Vaccination: A Systematic Review and Meta-Analysis
- A Systematic Review of Practice-, Provider-, and Patient-level Determinants Impacting Asian-Americans’ Human Papillomavirus Vaccine Intention and Uptake
- African-Caribbean Cancer Consortium
- HPV Vaccine Uptake among Daughters of Latinx Immigrant Mothers: Findings from a Cluster Randomized Controlled Trial of a Community-based, Culturally Relevant Intervention
- Northwest Portland Area Indian Health Board
- The Role of Trust in HPV Vaccine Uptake among Racial and Ethnic Minorities in the United States: a Narrative Review
3:15 p.m. Mission Control Check-In: Conclusion Remarks on Public Session
3:20 p.m. ADJOURN PUBLIC SESSION
DAY 2: June 10, 2021, 12:00 – 2:50 p.m. EST
12:00 p.m. SHOOTING FOR THE MOON: Meeting Open
- Hayley Arceneaux, St. Jude Children's Research Hospital, Inspiration4 Astronaut
12:05 p.m. WELCOME
- Kristin Oliver, Co-Chair, HPV Roundtable
- Rebecca Perkins, Co-Chair, HPV Roundtable
12:10 p.m. PANEL PRESENTATION: The Atmosphere Matters: Current Data on Insurance and Geography as Determinants of HPV Vaccination
How do we take research on key HPV vaccination determinants and apply it for action at the state level? This session will share recent research findings on effective interventions in rural communities and explore how immunization registries and geographic data mapping can target areas of low vaccination.
Moderator:
Speakers:
- Dr. Bernard Fuemmeler, Virginia Commonwealth University
- Dr. Whitney Zahnd, University of Iowa
- Courtnay Londo, American Immunization Registry Association
Suggested Pre-Reading:
- A Narrative Review of HPV Vaccination Interventions in Rural U.S. Communities
- Area-Level Variation and Human Papillomavirus Vaccination among Adolescents and Young Adults in the United States: A Systematic Review
- Spatial Access to Vaccines for Children Providers in South Carolina: Implications for HPV Vaccination (cdc.gov)
- AIRA
Bonus Background Materials:
- BCBS Health of America HPV Infographic
- Primary Care Use Among Commercially Insured Adolescents: Evidence from the 2018 Healthcare Effectiveness Data & Information Set
- Trends in Human Papillomavirus Vaccination in Commercially Insured Children in the United States
- The Association between State Medicaid Expansion and Human Papillomavirus Vaccination
1:00 p.m. HPV Survivor Impact Story
- Kim McClellan, President, Recurrent Respiratory Papillomatosis Foundation (RRPF)
- Eden, Lisa & Jim Tansey, RRP patient, mom and dad
1:10 p.m. PANEL PRESENTATION: Best and Promising Practices to Achieve New Heights in HPV Vaccination Rates: Start at Age 9
Data continue to show the HPV vaccine is safe and effective, yet HPV vaccination rates remain well below national goals and other vaccines that are part of the “adolescent platform.” What can the evidence tell us about the potential benefits and challenges of routinely starting HPV vaccination at age nine? Would starting HPV vaccination at age nine increase HPV uptake and on-time completion? Are providers willing to recommend HPV vaccine at age nine and is it an easier interaction with parents when they do? What does this practice look like in an actual clinic? This panel will explore answers to these questions and more.
Moderator:
Speakers:
- Dr. Rebecca Perkins, Boston University
- Dr. Melissa Gilkey, UNC
- Dr. Sherri Zorn, The Polyclinic, WA
Suggested Pre-Reading:
- ACS Updates HPV Vaccination Recommendations to Start at Age 9
- Why AAP Recommends Initiating HPV Vaccination as Early As Age 9
2:00 p.m. SPACE WALK
2:10 p.m. VaxTeen Video with Kelly Danielpour
Eight health systems joined a national HPV learning collaborative launched in early 2020. There were challenges, there were wins and there was commitment! Hear from AMGA’s analytic and population health team members on lessons learned on adolescent vaccination and effective interventions during the pandemic. The data tells an impressive story you’ll want to see.
Speakers:
- Dr. Elizabeth Ciemins, VP of Research & Analytics, AMGA
- Cori Rattelman, Sr. Research Analyst, AMGA
- Earlean Chambers, Director of Clinical and Quality Population Health Initiatives, AMGA
2:45 p.m. CANCER SURVIVORS & HPV VACCINATION
2:50 p.m. PUBLIC CLOSING REMARKS: Mission Command to Health Care
3:00 p.m. PUBLIC MEETING ADJOURNS